Patents Assigned to New Day Diagnostics, LLC
  • Methods and nucleic acids for determining the prognosis of a cancer subject
    Patent number: 12110558
    Abstract: The invention provides methods, nucleic acids and kits for determining the prognosis of a subject having cancer. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of said disorder, thereby enabling the improved diagnosis and treatment of patients.
    Type: Grant
    Filed: January 18, 2022
    Date of Patent: October 8, 2024
    Assignee: New Day Diagnostics, LLC
    Inventors: Jörn Lewin, Manuel Krispin
  • Methods for detecting CpG methylation and for diagnosing cancer
    Patent number: 12054786
    Abstract: The present invention relates to the field of pharmacogenomics and in particular to detecting the presence or absence of hypermethylated DNA. The detection of CpG methylation in marker DNA is useful for the diagnosis of cancers and the invention provides improved methods for this purpose. These improved methods allow in particular for a more sensitive detection of methylated marker DNA with high backgrounds of unmethylated marker DNA.
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: August 6, 2024
    Assignee: New Day Diagnostics, LLC
    Inventors: Denise Kottwitz, Jorn Lewin, Anne Schlegel, Reimo Tetzner